JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3751
MP Materials
MP
$8.37B
| $1.21M | ﹤0.01% |
37,605
-76,742
| -67% | -$3.1M |
2021 Q2
4 quarters
|
|
3752
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.74B
| $1.21M | ﹤0.01% |
15,744
-249,652
| -94% | -$20.9M |
2018 Q4
14 quarters
|
|
|
JAMF
3753
DELISTED
Jamf
JAMF
| $1.21M | ﹤0.01% |
48,655
+21,811
| +81% | +$611K |
2020 Q3
7 quarters
|
|
|
NIMC
3754
DELISTED
NiSource Inc. Series A Corporate Units
NIMC
| $1.21M | ﹤0.01% |
10,600
-34,500
| -76% | -$3.99M |
2021 Q4
2 quarters
|
|
|
SAVE
3755
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.2M | ﹤0.01% |
50,500
+21,200
| +72% | +$470K |
2022 Q1
1 quarter
|
|
3756
PUT
Yum! Brands
YUM
$37.1B
| $1.2M | ﹤0.01% |
10,600
+7,300
| +221% | +$849K |
2021 Q1
5 quarters
|
|
|
GTPA
3757
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $1.2M | ﹤0.01% |
122,878
-231,502
| -65% | -$2.27M |
2022 Q1
1 quarter
|
|
3758
Forrester Research
FORR
$214M
| $1.2M | ﹤0.01% |
25,035
-15,513
| -38% | -$804K |
2016 Q2
24 quarters
|
|
|
VLDR
3759
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $1.2M | ﹤0.01% |
1,253,828
-330,015
| -21% | -$570K |
2020 Q4
6 quarters
|
|
3760
Horizon Bancorp
HBNC
$1B
| $1.19M | ﹤0.01% |
68,573
+10,706
| +19% | +$190K |
2017 Q4
18 quarters
|
|
|
PRA
3761
DELISTED
ProAssurance
PRA
| $1.19M | ﹤0.01% |
50,537
-170,480
| -77% | -$4M |
2013 Q2
36 quarters
|
|
3762
Amneal Pharmaceuticals
AMRX
$7.07B
| $1.19M | ﹤0.01% |
374,401
+11,016
| +3% | +$39.9K |
2018 Q2
16 quarters
|
|
3763
Viant Technology
DSP
$259M
| $1.19M | ﹤0.01% |
233,384
+110,967
| +91% | +$665K |
2021 Q1
5 quarters
|
|
3764
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.48B
| $1.19M | ﹤0.01% |
22,234
+9,351
| +73% | +$518K |
2019 Q2
12 quarters
|
|
3765
QuantumScape Corp
QS
$2.81B
| $1.18M | ﹤0.01% |
137,821
-192,751
| -58% | -$2.57M |
2020 Q3
7 quarters
|
|
|
AESC
3766
DELISTED
The AES Corporation
AESC
| $1.18M | ﹤0.01% |
13,700
-30,000
| -69% | -$2.67M |
2021 Q4
2 quarters
|
|
3767
BlackRock Floating Rate Income Strategies Fund
FRA
$372M
| $1.18M | ﹤0.01% |
103,665
| – | – |
2017 Q4
18 quarters
|
|
3768
Sylvamo
SLVM
$1.29B
| $1.18M | ﹤0.01% |
36,137
-51,071
| -59% | -$2.14M |
2021 Q4
2 quarters
|
|
3769
MacroGenics
MGNX
$228M
| $1.18M | ﹤0.01% |
399,054
+115,294
| +41% | +$606K |
2013 Q4
34 quarters
|
|
3770
PUT
Avis
CAR
$3.93B
| $1.18M | ﹤0.01% |
+8,000
| New | +$1.75M |
2022 Q2
0 quarters
|
|
|
EOCW.U
3771
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
| $1.18M | ﹤0.01% |
120,000
| – | – |
2021 Q3
3 quarters
|
|
3772
iShares US Consumer Staples ETF
IYK
$1.37B
| $1.17M | ﹤0.01% |
18,021
-762
| -4% | -$51.2K |
2017 Q4
18 quarters
|
|
3773
Blue Owl Capital
OBDC
$5.08B
| $1.17M | ﹤0.01% |
94,966
+17,466
| +23% | +$239K |
2021 Q4
2 quarters
|
|
3774
Gibraltar Industries
ROCK
$1.19B
| $1.17M | ﹤0.01% |
30,180
-3,649
| -11% | -$149K |
2013 Q2
36 quarters
|
|
3775
Endava
DAVA
$101M
| $1.17M | ﹤0.01% |
13,235
+2,994
| +29% | +$313K |
2020 Q1
9 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.